Evaluation of MRI for initial staging of esophageal cancer: the STIRMCO study - Takeaways - MDSpire

Evaluation of MRI for initial staging of esophageal cancer: the STIRMCO study

  • By

  • Vincent Levy

  • Mario Jreige

  • Laura Haefliger

  • Celine Du Pasquier

  • Camille Noirot

  • Anna Dorothea Wagner

  • Styliani Mantziari

  • Markus Schäfer

  • Naik Vietti-Violi

  • Clarisse Dromain

  • May 16, 2025

  • 0 min

Share

  • 1

    Esophageal cancer is a leading cause of cancer-related mortality, with a poor 5-year survival rate of 12%, particularly affecting younger individuals.

  • 2

    Accurate initial staging of esophageal cancer is crucial for determining appropriate therapeutic strategies, including surgery and chemoradiotherapy.

  • 3

    MRI shows potential as an alternative to EUS for locoregional tumor staging, offering high precision and the ability to assess stenotic tumors.

  • 4

    The STIRMCO study aims to compare the diagnostic performance of MRI combined with PET/CT against conventional imaging methods for staging esophageal cancer.

  • 5

    MRI provides advantages such as no ionizing radiation and improved soft tissue differentiation, making it a promising tool for esophageal cancer staging.

Original Source(s)

Evaluation of MRI for initial staging of esophageal cancer: the STIRMCO study

  • by Vincent Levy, Mario Jreige, Laura Haefliger, Celine Du Pasquier, Camille Noirot, Anna Dorothea Wagner, Styliani Mantziari, Markus Schäfer, Naik Vietti-Violi, Clarisse Dromain

  • May 16, 2025

Related Content

Radiotherapy plus immunotherapy with or without chemotherapy improves survival in elderly esophageal squamous cell carcinoma: a real-world comorbidity-stratified study

PET/CT and MRI Model May Help Stratify Prostate Cancer Risk

Retrospective multicenter radiomics study showed moderate to high discrimination in two small external cohorts

CT Use May Add to Future Cancer Burden

Researchers projected approximately 103,000 future cancers associated with computed tomography examinations performed in the US in 2023.